ATF2 and allergic asthma: The results presented here demonstrate that ATF2 is a novel mediator of GSH dynamics in MSCs that acts via interplay with the NRF2 signaling cascade, thereby affecting the functionality and therapeutic potency of MSCs toward allergic asthma.